The efficacy of risk model scores to predict venous thromboembolism (VTE) in ambulatory cancer patients is under investigation, aiming to stratify on an individual risk basis the subset of the cancer population that could mostly benefit from primary thromboprophylaxis
Venous thromboembolism (VTE) often complicates the clinical course of cancer disease. The risk is fu...
International audienceVenous thromboembolism (VTE) is an independent prognostic factor and the secon...
Venous thromboembolism (VTE) is a frequent complication of lung cancer and its treatment, especially...
The efficacy of risk model scores to predict venous thromboembolism (VTE) in ambulatory cancer patie...
Venous thromboembolism (VTE) is a significant cause of mortality in patients with lungcancer. Despit...
Background: The awareness of venous thromboembolism (VTE) burden in ambulatory cancer patients is g...
Venous thromboembolism (VTE) is frequent among patients with cancer. Ambulatory cancer patients star...
Background: Venous thromboembolism (VTE) is a common complication of cancer. This study aimed to eva...
Venous thromboembolism (VTE) is a frequent complication in patients with cancer and is associated wi...
Venous thromboembolism (VTE) is a significant cause of mortality in patients with lung cancer. Despi...
Introduction: Venous thromboembolism (VTE) is a common complication in patients with cancer and has ...
Venous thromboembolism (VTE) is a frequent complication in patients with cancer and is associated wi...
Recent data suggest that patients with a malignancy have a seven-fold increased risk for venous thro...
Background: Venous thromboembolism (VTE) remains one of the most important causes of mortality and m...
Ambulatory cancer patients receiving systemic cancer therapy are at varying risk for venous thromboe...
Venous thromboembolism (VTE) often complicates the clinical course of cancer disease. The risk is fu...
International audienceVenous thromboembolism (VTE) is an independent prognostic factor and the secon...
Venous thromboembolism (VTE) is a frequent complication of lung cancer and its treatment, especially...
The efficacy of risk model scores to predict venous thromboembolism (VTE) in ambulatory cancer patie...
Venous thromboembolism (VTE) is a significant cause of mortality in patients with lungcancer. Despit...
Background: The awareness of venous thromboembolism (VTE) burden in ambulatory cancer patients is g...
Venous thromboembolism (VTE) is frequent among patients with cancer. Ambulatory cancer patients star...
Background: Venous thromboembolism (VTE) is a common complication of cancer. This study aimed to eva...
Venous thromboembolism (VTE) is a frequent complication in patients with cancer and is associated wi...
Venous thromboembolism (VTE) is a significant cause of mortality in patients with lung cancer. Despi...
Introduction: Venous thromboembolism (VTE) is a common complication in patients with cancer and has ...
Venous thromboembolism (VTE) is a frequent complication in patients with cancer and is associated wi...
Recent data suggest that patients with a malignancy have a seven-fold increased risk for venous thro...
Background: Venous thromboembolism (VTE) remains one of the most important causes of mortality and m...
Ambulatory cancer patients receiving systemic cancer therapy are at varying risk for venous thromboe...
Venous thromboembolism (VTE) often complicates the clinical course of cancer disease. The risk is fu...
International audienceVenous thromboembolism (VTE) is an independent prognostic factor and the secon...
Venous thromboembolism (VTE) is a frequent complication of lung cancer and its treatment, especially...